
### [NCIT:C9330](http://purl.obolibrary.org/obo/NCIT_C9330)
**Label:** Appendix Carcinoma

**Subclasses:** [NCIT:C134125](http://purl.obolibrary.org/obo/NCIT_C134125) (Stage III Appendix Carcinoma AJCC v8), [NCIT:C134118](http://purl.obolibrary.org/obo/NCIT_C134118) (Stage 0 Appendix Carcinoma AJCC v8), [NCIT:C134129](http://purl.obolibrary.org/obo/NCIT_C134129) (Stage IV Appendix Carcinoma AJCC v8), [NCIT:C5511](http://purl.obolibrary.org/obo/NCIT_C5511) (Appendix Mucinous Cystadenocarcinoma), [NCIT:C96421](http://purl.obolibrary.org/obo/NCIT_C96421) (High Grade Appendix Mucinous Adenocarcinoma), [NCIT:C133733](http://purl.obolibrary.org/obo/NCIT_C133733) (Appendix Carcinoma by AJCC v7 Stage), [NCIT:C134117](http://purl.obolibrary.org/obo/NCIT_C134117) (Appendix Carcinoma by AJCC v8 Stage), [NCIT:C3689](http://purl.obolibrary.org/obo/NCIT_C3689) (Appendix Goblet Cell Carcinoid), [NCIT:C4593](http://purl.obolibrary.org/obo/NCIT_C4593) (Stage 0 Appendix Carcinoma AJCC v7), [NCIT:C43564](http://purl.obolibrary.org/obo/NCIT_C43564) (Appendix Mixed Adenoneuroendocrine Carcinoma), [NCIT:C43554](http://purl.obolibrary.org/obo/NCIT_C43554) (Appendix Signet Ring Cell Carcinoma), [NCIT:C134121](http://purl.obolibrary.org/obo/NCIT_C134121) (Stage II Appendix Carcinoma AJCC v8), [NCIT:C43555](http://purl.obolibrary.org/obo/NCIT_C43555) (Appendix Small Cell Neuroendocrine Carcinoma), [NCIT:C134120](http://purl.obolibrary.org/obo/NCIT_C134120) (Stage I Appendix Carcinoma AJCC v8), [NCIT:C43556](http://purl.obolibrary.org/obo/NCIT_C43556) (Appendix Undifferentiated Carcinoma), [NCIT:C43558](http://purl.obolibrary.org/obo/NCIT_C43558) (Appendix Mucinous Adenocarcinoma), [NCIT:C42598](http://purl.obolibrary.org/obo/NCIT_C42598) (Low-Grade Appendiceal Mucinous Neoplasm), [NCIT:C87798](http://purl.obolibrary.org/obo/NCIT_C87798) (Stage I Appendix Carcinoma AJCC v7), [NCIT:C96425](http://purl.obolibrary.org/obo/NCIT_C96425) (Appendix Neuroendocrine Carcinoma), [NCIT:C96426](http://purl.obolibrary.org/obo/NCIT_C96426) (Appendix Large Cell Neuroendocrine Carcinoma), [NCIT:C134119](http://purl.obolibrary.org/obo/NCIT_C134119) (Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8), [NCIT:C7718](http://purl.obolibrary.org/obo/NCIT_C7718) (Appendix Adenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36685](http://purl.obolibrary.org/obo/NCIT_C36685) (NF1 Gene Inactivation))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36684](http://purl.obolibrary.org/obo/NCIT_C36684) (WT1 Gene Inactivation))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36683](http://purl.obolibrary.org/obo/NCIT_C36683) (APC Gene Inactivation))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36681](http://purl.obolibrary.org/obo/NCIT_C36681) (MDM2 Gene Amplification))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36679](http://purl.obolibrary.org/obo/NCIT_C36679) (HRAS Gene Amplification))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36678](http://purl.obolibrary.org/obo/NCIT_C36678) (FOS Gene Amplification))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36673](http://purl.obolibrary.org/obo/NCIT_C36673) (NMYC Gene Amplification))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36671](http://purl.obolibrary.org/obo/NCIT_C36671) (Gain of Chromosome 10))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36670](http://purl.obolibrary.org/obo/NCIT_C36670) (Gain of Chromosome 16))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36669](http://purl.obolibrary.org/obo/NCIT_C36669) (Gain of Chromosome 6))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36667](http://purl.obolibrary.org/obo/NCIT_C36667) (Loss of Chromosome 4q))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36666](http://purl.obolibrary.org/obo/NCIT_C36666) (Fibroblast Growth Factor 1 Overexpression))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36665](http://purl.obolibrary.org/obo/NCIT_C36665) (KRAS Gene Amplification))) 39.52%


